SERPINB1在銀屑病中的表達(dá)及功能研究
[Abstract]:Study Background Psoriasis is a common chronic and recurrent inflammatory skin disease, which brings great pain to the body and mind of the patient, and has long been the focus of research in the field of skin diseases. The characteristic pathological change of psoriasis is the excessive proliferation of the keratinocytes and the aggregation of the neutrophils in the epidermis, and the neutrophil count in the peripheral blood of the patients with psoriasis is also High. Neutrophil is an important component of natural immunity, and can play an important role in the development of psoriasis and disease progression through a variety of ways. An important medium in which the neutrophil is active is a neutrophil elastase, N E). The existing studies have shown that NE has the effects of promoting the inflammatory reaction, and has the effect of inhibiting the inflammatory reaction, and the NE plays a very complicated role in the inflammatory reaction. The study of the relationship between NE and psoriasis has shown that NE is highly expressed in the skin of the patients with psoriasis and is parallel to the condition, and it has been shown that NE can stimulate the cutin shape through the EGFR signaling pathway. In that case of psoriasis, the proliferation of the keratinocytes, IL-8, IL-6, and ICAM-1 and the expression of NE and its inhibitor in psoriasis were decrease. There is an imbalance in the medium. However, there is no study to directly observe whether the corresponding NE inhibitor can inhibit the formation of the cutin caused by the NE. It is shown that the low concentration of NE can increase the transcription of the cells and the expression of the NE inhibitor elafin, and the high concentration of NE makes elafi n-expression is reduced. However, the relationship between NE and its inhibitor and the regulation of its expression level lack further The present vitamin D3 analog is the most effective in the treatment of light and moderate psoriasis. One of the most common forms of external use. The study on its treatment mechanism has also been In the study of the prophase, we found that calcitriol acts on HaCaT, and the egg-albumin-like serine protease inhibitor 1 (serine protein inhibitor, clade B, member 1, SERPINB1) (monocyte neutopia inhibisitor, MNEI) The expression of protein is increased, and it is suggested that SERPINB1 is in the process of treating psoriasis with calcitriol. SERPINB1 is a fast-reactive inhibitor of a neutrophil-protease inhibitor, which can inhibit the NE and the tissue protein. Enzyme G (cat G). At present, the study on SERPINB1 in the inflammatory diseases of PMNs, especially acute lung injury and the infection of pulmonary pseudomonas aeruginosa, has been in-depth: it is confirmed that it is in the regulation of natural immunity. It is important to play an important role, but with regard to the closure of SERPINB1 and psoriasis The results of this study, on the basis of the previous subject, further verified the changes of the level of SERPINB1 in the level of gene and protein, the expression of SERPINB1 in the skin of psoriasis, and the further study of SERPIN1 on the proliferation of keratinocytes. And the effect of SERPINB1 in the treatment of psoriasis is verified, and a new treatment for the treatment of psoriasis is carried out. The first part of calcitriol has a certain guiding significance, and the first part of calcitriol is formed in the cu@@ Objective: To study the effect of calcitriol on human immortalized keratinocytes (HaCaT) SER. Methods: In the conventional culture of HaCaT cells and the growth of cells to 80% fusion, fresh formulated 10-8 mol/ L calcitriol was added, and the negative control group was added with the same amount of serum-free medium. The total RNA and total protein of the cells were analyzed by RT-PCR and western-blot, and different time points were set. The effect of drug on SERPIN1 mRNA was observed. Results: Compared with the blank control after the action of calcitriol on HaCaT, the SERPINB1 mRNA was up to 1.99 times,8 h,12 h,24 h and 48 h, respectively, up to 2.41, 3.28, 3.46 and 3.31 times, and the same as 0 h. The difference was of statistical significance, and there was no statistical significance between the time groups. In the level of protein,24 h and 48 h, there was an increase in the level of protein,24 h and 48 h, and the difference was statistically significant. Conclusion: The calcitriol can be promoted. Expression of SERPINB1mRNA and Protein in HaCaT. Part II SERP The effect of INB1 on the proliferation of HaCaT and the control of the NE to SERPINB1: the siR of the effective SERPINB1 is selected. NA, by gene interference study SERPINB1 vs. Ha The effects of different concentrations of NE on SERPINB1 were studied. Methods: The siRNA of SERPINB1 was designed and synthesized by RNA interference,3 pairs were designed, and the HaCaT cells were transfected with the Lipofectamine 2000 transfection method. The transfection efficiency was observed by the siRNA of the fluorescent label. The efficiency of transfection and interference was verified by RT-PCR, and the most effective siRNA, SERPINB, was selected. 1-homo-93, using S ERPINB1-homoo-93 interferes with HaCaT to observe the MTT of cells before and after interference. HaCaT, by western-blot, SERP was observed INB1 The effects of NE and calcitriol on the proliferation of HaCaT were observed. -homoo-93 can effectively interfere with the SERPINB1 of HaCaT, and the interference efficiency 2. NE could promote the proliferation of cells in a concentration of 1 U/ L-15 U/ L. The effect of the concentration of 15 U/ L on the proliferation of cells was similar to that of the blank. In contrast, there was no significant difference in cell proliferation at a concentration of 20 U/ L-50 U/ L.3. Ossification The proliferation of HaCaT was inhibited by triol at 10-9-10-6 mol/ L. The inhibition of the proliferation of calcitriol could not compensate for the effect of interfering with SERPINB1 on proliferation.5. When NE 1,5,10,15 U/ L at low concentration, SERPINB1/ GAPDH could be increased, and the concentration of protein increased with the concentration of NE at 20 U/ L. The concentration of NE was 33.3 and 50U/ L. The inhibitory effect of SERPIN1 on the concentration of SERPIN1 protein was found. and the proliferation is inhibited; the low-concentration NE promotes the SERPINB; 1 Expression, inhibition of SERPINB1 expression at high concentrations. Part III silver Objective: To study the expression of SERPINB1 in psoriatic lesions. To damage the normal control skin specimen, the total protein of the tissue was extracted, and the SERPIN was analyzed by western-blot. The difference in the amount of B1 was collected. The difference in the amount of SERPINB1 in the tissue section was observed by immunohistochemistry using a wax block in a prior psoriatic biopsy patient. 涓璖ERPINB1 SERPINB1 was diffuse in the skin of the psoriatic lesions in the presence of weak to medium-positive staining in the basal layer In the base layer, the strong positive staining was found in the ratchet layer. The difference was statistically significant. The fresh tissue SERPINB1/ GAP DH was lower in the psoriatic group than in the normal control group. Conclusion: The paraffin section of psoriatic lesions
【學(xué)位授予單位】:第二軍醫(yī)大學(xué)
【學(xué)位級(jí)別】:博士
【學(xué)位授予年份】:2011
【分類號(hào)】:R758.63
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 于華平;;阿維A治療銀屑病60例臨床分析[J];醫(yī)學(xué)信息(上旬刊);2011年08期
2 郭黎光;張義梅;;分步綜合療法治療銀屑病的研究及臨床應(yīng)用[J];中國(guó)民間療法;2011年08期
3 舒慧敏;;清開靈注射液治療尋常性銀屑病療效觀察[J];中國(guó)民族民間醫(yī)藥;2011年11期
4 吳軍;;與心血管病的關(guān)聯(lián)——銀屑病(牛皮癬)[J];心血管病防治知識(shí);2009年10期
5 趙德成;趙璐;;銀屑病與惡性腫瘤探討[J];中國(guó)民族民間醫(yī)藥;2011年16期
6 黃存垣;;銀屑病(松皮癬)的中醫(yī)調(diào)治[J];老友;2011年08期
7 白云飛;;銀屑病患者多伴發(fā)心血管疾病危險(xiǎn)因素[J];心血管病防治知識(shí);2007年03期
8 衛(wèi)建明;李渝;馬維那;龍?jiān)?;窄譜中波紫外線治療107例銀屑病臨床療效觀察[J];實(shí)用臨床醫(yī)藥雜志;2011年13期
9 范霞;姜功平;范平;;銀屑病并發(fā)假性斑禿1例[J];咸寧學(xué)院學(xué)報(bào)(醫(yī)學(xué)版);2011年04期
10 朱月嬌;徐靜;陳瑜;林海云;陳蕾蕾;;心理干預(yù)在PUVA治療銀屑病患者中應(yīng)用效果評(píng)價(jià)[J];中國(guó)現(xiàn)代醫(yī)生;2011年19期
相關(guān)會(huì)議論文 前10條
1 閻衡;葉慶佾;郝飛;黃東平;唐書謙;黃秀英;張黎;;銀屑病患者外周血單個(gè)核細(xì)胞中CTLA_4mRNA及蛋白的表達(dá)[A];2001年中國(guó)中西醫(yī)結(jié)合皮膚性病學(xué)術(shù)會(huì)議論文匯編[C];2001年
2 陳明星;姚亞南;王愛民;金群;;銀康顆粒劑治療銀屑病252例臨床觀察[A];全國(guó)中藥研究學(xué)術(shù)討論會(huì)論文集[C];2003年
3 王冬云;彭振輝;譚升順;楚瑞奇;劉平;馬慧群;張盤諫;;PML表達(dá)在銀屑病發(fā)病機(jī)理中的作用[A];2003中國(guó)中西醫(yī)結(jié)合皮膚性病學(xué)術(shù)會(huì)議論文匯編[C];2003年
4 趙艷霞;陳學(xué)榮;李東明;;單味中藥及其提取制劑治療銀屑病的臨床應(yīng)用[A];2003中國(guó)中西醫(yī)結(jié)合皮膚性病學(xué)術(shù)會(huì)議論文匯編[C];2003年
5 唐雋;郝飛;;銀屑病治療的評(píng)價(jià)[A];中華醫(yī)學(xué)會(huì)第14次全國(guó)皮膚性病學(xué)術(shù)年會(huì)論文匯編[C];2008年
6 楊佃會(huì);王健;單秋華;趙穎;韓晶;;耳穴綜合療法治療穩(wěn)定期銀屑病的臨床療效觀察[A];2011中國(guó)針灸學(xué)會(huì)年會(huì)論文集(摘要)[C];2011年
7 鄭敏;滿孝勇;李偉;周炯;陳佳琦;李春明;蔡綏R,
本文編號(hào):2480821
本文鏈接:http://sikaile.net/yixuelunwen/pifb/2480821.html